Bifogade filer
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Industri |
| Industri | Industriprodukter |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
QleanAir AB (publ), a leading provider of solutions for clean indoor air, has signed two separate agreements to provide new USP 797/800 compliant cleanroom environment for pharmacy compounding services. The two agreements are signed with customers in Florida and the US Southeast, with both projects expected to be completed by the end of Q4 2026.
QleanAir is dedicated to being an excellent partner through building and maintaining modular cleanrooms that exceed USP guidelines and maintain a compliant state of control. A large academic health system in the Southeast, with 20 hospital campuses, over 900 clinics, and approximately 56,000 employees, has signed an agreement for its twelfth QleanAir cleanroom. The customer’s first QleanAir cleanroom is nearly 10 years old and remains fully functional and compliant. The order value for this project is approximately $1.02M USD.
– “Twelve cleanrooms with a single customer is a milestone that speaks for itself. It reflects the trust that comes from years of consistent performance, compliance, and partnership. We are proud to continue supporting one of the largest academic health systems in the Southeast.” says Zachary Douglas, President of QleanAir Scandinavia Inc.
In a second agreement, a 244-bed fully integrated medical campus on Florida’s Treasure Coast, part of one of the world’s most recognized health systems, has signed a $499,000 USD contract for its third QleanAir cleanroom.
– “We are proud to continue growing our partnership with one of the most recognized names in healthcare. A third cleanroom project reinforces the value our customers see in QleanAir’s quality, compliance, and service model.” says Zachary Douglas, President of QleanAir Scandinavia Inc.
Both projects are expected to be completed by the end of Q4 2026.